9-ING-41 in Patients With Advanced Cancers
Actuate Therapeutics Inc.
Actuate Therapeutics Inc.
M.D. Anderson Cancer Center
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
Infinity Pharmaceuticals, Inc.
University of California, San Francisco